COMMUNIQUÉS West-GlobeNewswire

New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life
14/07/2025
COPENHAGEN, Denmark, July 14, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 156 of its Phase 3 PaTHway Trial confirming that long-term treatment with TransCon PTH ( [...]
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
14/07/2025
Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July 14, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 [...]
Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings
14/07/2025
Increases total holdings to 1,427,178 HYPE LAGUNA HILLS, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), a pioneer in ophthalmic technologies and the [...]
Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary
14/07/2025
SOUTH SAN FRANCISCO, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today [...]
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
14/07/2025
Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or [...]
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
14/07/2025
SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second [...]
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
14/07/2025
PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging (“Longevity”, the “Company”, “we”, “our”, or “us”), today announced [...]
Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)
14/07/2025
Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 revenue [...]
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
14/07/2025
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, [...]
ASAP Dental Care Marks Milestone in Dental Implants with Over 9,600 Procedures Performed
14/07/2025
Jacksonville, FL, July 14, 2025 (GLOBE NEWSWIRE) -- ASAP Dental Care, a leading provider of dental implants in Jacksonville and across Northeast Florida, has achieved a significant milestone in its surgical operations [...]
Total Orthopedics and Sports Medicine Expands Multi-Specialty Spine and Orthopedic Care in New York
14/07/2025
Total Orthopedics and Sports Medicine delivers coordinated, patient-centered orthopedic care across 14 New York locations. With over 20 board certified physicians, including Dr. Dante Leven, the practice offers [...]
Kane Biotech to Present at Advanced Wound Care Summit USA
14/07/2025
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr. Robert Huizinga, will be [...]
Strength Training For Women: CrazyBulk Legal Steroid Alternatives Are Changing the Muscle Building Supplements Game
14/07/2025
Strength training for women evolves in 2025 as CrazyBulk supplements offer legal, female-friendly alternatives to anabolic steroids for safe muscle building. New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- [...]
Muscle Endurance: Bodybuilders Turn to CrazyBulk Natural Legal Steroids and BodyBuilding Supplements For Muscle Growth
14/07/2025
CrazyBulk leads 2025 with natural legal steroids built for endurance, recovery, and lean strength—no needles, no risks, just clean performance New York City, NY, July 14, 2025 (GLOBE NEWSWIRE) -- As the fitness world [...]
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue
14/07/2025
ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. ( OTC: BLEG ), a diversified holdings company, today announced significant changes in its leadership structure and a strategic merger [...]
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
14/07/2025
Tevogen.AI’s model drastically reduces target analysis and has the potential to generate billions in cost savings across the healthcare system by streamlining early-stage drug discovery, reducing wet lab dependency, and [...]
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
14/07/2025
SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- TTAM Research Institute (“TTAM”), a nonprofit public benefit corporation based in California and founded and led by Anne Wojcicki, today announced that it has completed [...]
Ascentage Pharma Announces Pricing of Top-Up Placement
14/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 14, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855) (“ Ascentage ” or the “ Company ”), a global biopharmaceutical company dedicated [...]
The Foundation for Sarcoidosis Research Awards $450,000 to Support Early-Career Investigators Through the 2025 Fellowship Grant
14/07/2025
CHICAGO, July 14, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the three recipients of the 2025 FSR Early Career Fellowship Grant : William Lippitt, PhD, (University of [...]

Pages